It only took about a month for BA.2.12.1, an Omicron subvariant, to cause most of the new COVID-19 cases in the U.S. since scientists first spotted it in the country. But even newer iterations of the Omicron variant are spreading rapidly through the U.S. and are poised to outcompete past versions […]
Read More
Abstract BACKGROUND Sabizabulin is an oral, novel microtubule disruptor that has dual antiviral and anti-inflammatory activities in preclinical models. METHODS A randomized, multicenter placebo-controlled phase 3 clinical trial was conducted with hospitalized patients with moderate to severe Covid-19 who were at high risk for acute respiratory distress syndrome (ARDS) and […]
Read More
México atraviesa su quinta ola de COVID-19, esto luego de más de un mes con aumentos de casos diarios, que comenzaron con cifras de 6 mil nuevos contagios y que actualmente se han superado los 31 mil en 24 horas, teniendo cifras similares a las de enero y febrero de este […]
Read More
La pandemia del coronavirus parece no tener fin, al menos en un futuro inmediato. Y es que la comunidad científica ha alertado del surgimiento de una nueva súper variante de la covi-19 llamada: BA 2.75. La nueva cepa se destaca por su alto nivel de contagio: cinco veces más que […]
Read More
About Vaccination for Children and Teens CDC recommends COVID-19 vaccines for everyone 6 months and older and boosters for everyone 5 years and older, if eligible. Use CDC’s COVID-19 booster tool to learn if and when your child or teen can get boosters to stay up to date with their COVID-19 vaccines. […]
Read More
COVID-19 was the third leading cause of death in the United States between March 2020 and October 2021, according to an analysis of national death certificate data by researchers at the National Cancer Institute, part of the National Institutes of Health. The study appears July 5 in JAMA Internal Medicine. During […]
Read More
Multisystem inflammatory syndrome in children (MIS-C) is a serious complication of SARS-CoV-2 infection.1 A previous study that described MIS-C cases in the first 3 waves of the COVID-19 pandemic found that the proportion of individuals with severe illness declined after the first wave.2 In Israel, the Omicron (B.1.1.529) variant started to spread […]
Read More
El Centro Europeo para la Prevención y el Control de Enfermedades (ECDC, por sus siglas en inglés), alertaba hace algunas semanas de la expansión de los linajes de la variante Ómicron del SARS-CoV-2 (B.1.1.529, detectada originalmente en Sudáfrica) BA.4 y BA.5. Estos cuentan con una serie de mutaciones que les confieren un mayor escape inmunitario aunque, en principio, no provocan […]
Read More
The benefits of maternal vaccination to the infant through maternal antibody transfer across the placenta have long been recognized. In the 1870s, babies born to mothers who had received smallpox vaccination were unlikely to have smallpox early in life.1 Tetanus toxoid vaccination during pregnancy, along with improved hygiene during delivery, has […]
Read More
Con el objetivo de mejorar las pruebas de diagnóstico Covid, así como las de otros virus, un grupo de investigación del Instituto de Biología Integrativa de Sistemas (I2SysBio), centro mixto del Consejo Superior de Investigaciones Científicas (CSIC) y la Universidad de Valencia (UV) ha desarrollado un método mediante la técnica de edición genética conocida como […]
Read More